Personalized Medicine for Head and Neck Cancer

This course will provide an overview of the mutational landscape differences between HPV-positive and -negative head and neck squamos cell carcinoma and practitioners will take away how the mutational profile may impact treatment decisions for each patient.

Target Audience

Primary Care Physicians, Otolaryngologists, Gastroenterologists, Radiologists, Medical Oncologists, Oral Maxillofacial Surgeons, Surgeons, Pathologists, Hospitalists and Physician Assistants.

Learning Objective

  • Describe the mutational landscape differences between HPV-positive and -negative head and neck squamous cell carcinoma and explain how the mutational profile may impact treatment decisions for each patient.
Additional information
Bibliography: 
  • Sacco, A. G., & Cohen, E. E. (2015). Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. Journal of clinical oncology, 33(29), 3305-3313.
  • Vermorken, J. B., & Specenier, P. (2010). Optimal treatment for recurrent/metastatic head and neck cancer. Annals of oncology, 21(suppl_7), vii252-vii261.
  • Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., ... & Kim, H. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine, 363(1), 24-35.
  • Hayes et al ASCO 2013Hayes, D. N., Grandis, J. R., & El-Naggar, A. K. (2013). The Cancer Genome Atlas: Integrated analysis of genome alterations in squamous cell carcinoma of the head and neck.
  • Head Neck. 2016 Apr; 38(Suppl 1): E1625–E1638.

Related Topics

Miami Cancer Institute Online Series (Multiple Modules)
This online educational series features Miami Cancer Institute (MCI) physician experts and national subject matter experts who have presented at our recent symposiums. Topics highlight the latest advances in cancer imaging, chemotherapy, surgical interventions, radiotherapy and proton therapy. Visit us often, as this catalog will be updated frequently.
Course Summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 General certificate of attendance
Course opens: 
04/01/2019
Course expires: 
04/01/2021

Guilherme Rabinowits, M.D.
Lead Physician, Head and Neck Medical Oncology
Miami Cancer Institute, Baptist Health South Florida
Associate Professor of Medicine
Herbert Wertheim College of Medicine, Florida International University

Guilherme Rabinowits, M.D., indicated that he is a consultant with Pfizer, Merck, Sanofi, Castel, Lighthouse, EMD Serono and Regeneron and a shareholder with Regeneron and Syros Pharmaceuticals.

Geoffrey Young, M.D., conference director, indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 General certificate of attendance
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome		Microsoft Edge
Microsoft Edge		Safari
Safari		Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.